Endoglin regulates mural cell adhesion in the circulatory system

Cellular and Molecular Life Sciences

Volumn 73, Issue 8, 2016, Pages 1715-1739

  Rossi, Elisa ^a,b,c,d   Smadja, David M ^d,e   Boscolo, Elisa ^f   Langa, Carmen ^a,b   Arevalo, Miguel A ^g,h   Pericacho, Miguel ^h,i   Gamella Pozuelo, Luis ^a,b,i   Kauskot, Alexandre ^j,k   Botella, Luisa M ^a,b   Gaussem, Pascale ^d,e   Bischoff, Joyce ^f   Lopez Novoa, José M ^h,i   Bernabeu, Carmelo ^a,b  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e Fondation Carpentier   (France)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF SALAMANCA   (Spain)

^h INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

ⁱ UNIVERSITY OF SALAMANCA   (Spain)

^j Dept Environ Med Natl Inst Publ HIth   (Norway)

^k UNIVERSITÉ PARIS SACLAY   (France)

more..

Author keywords

Blood vessels; Cell adhesion; HHT; Kidney; TGF ; Tubulogenesis

Indexed keywords

ANTIBODY; ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; ENDOGLIN; INTEGRIN ALPHA5BETA1 ANTIBODY; MEMBRANE PROTEIN; SOLUBLE ENDOGLIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROTEIN BINDING; SMALL INTERFERING RNA;

ABNORMAL URINE COMPOSITION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEREDITARY HEMORRHAGIC TELANGIECTASIA TYPE 1; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERICYTE; PODOCYTURIA; PREECLAMPSIA; PROTEIN BINDING; PROTEIN MOTIF; REGULATORY MECHANISM; RENDU OSLER WEBER DISEASE; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; GENETICS; JURKAT CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PODOCYTE; PREGNANCY; RETINA; RNA INTERFERENCE; SMOOTH MUSCLE CELL; TRANSGENIC MOUSE; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD29; CELL ADHESION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENDOGLIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; JURKAT CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PODOCYTES; PRE-ECLAMPSIA; PREGNANCY; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RETINA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 84949523371     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-015-2099-4     Document Type: Article

References (66)

1. Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193-215
2. Davis GE, Stratman AN, Sacharidou A, Koh W (2011) Molecular basis for endothelial lumen formation and tubulogenesis during vasculogenesis and angiogenic sprouting. Int Rev Cell Mol Biol 288:101-165
3. Stratman AN, Davis GE (2012) Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc Microanal 18:68-80
4. Aguilera KY, Brekken RA (2014) Recruitment and retention: factors that affect pericyte migration. Cell Mol Life Sci 71:299-309
5. Marcelo KL, Goldie LC, Hirschi KK (2013) Regulation of endothelial cell differentiation and specification. Circ Res 112:1272-1287
6. Murakami M (2012) Signaling required for blood vessel maintenance: molecular basis and pathological manifestations. Int J Vasc Med 2012:293641
7. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through hif-1 induction of sdf-1. Nat Med 10:858-864
8. Hamdan R, Zhou Z, Kleinerman ES (2011) Sdf-1alpha induces pdgf-b expression and the differentiation of bone marrow cells into pericytes. Mol Cancer Res 9:1462-1470
9. Döring Y, Pawig L, Weber C, Noels H (2014) The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. Front Physiol 5:212
10. ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857-869
11. Silva R, D'Amico G, Hodivala-Dilke KM, Reynolds LE (2008) Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol 28:1703-1713
12. Liu J, Zeng L, Kennedy RM, Gruenig NM, Childs SJ (2012) Betapix plays a dual role in cerebral vascular stability and angiogenesis, and interacts with integrin alphavbeta8. Dev Biol 363:95-105
13. Abraham S, Kogata N, Fassler R, Adams RH (2008) Integrin beta1 subunit controls mural cell adhesion, spreading, and blood vessel wall stability. Circ Res 102:562-570
14. van der Flier A, Badu-Nkansah K, Whittaker CA, Crowley D, Bronson RT, Lacy-Hulbert A, Hynes RO (2010) Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during development. Development 137:2439-2449
15. Chatterjee M, Gawaz M (2013) Platelet-derived cxcl12 (sdf-1alpha): basic mechanisms and clinical implications. J Thromb Haemost 11:1954-1967
16. Rossi E, Sanz-Rodriguez F, Eleno N, Düwell A, Blanco FJ, Langa C, Botella LM, Cabañas C, Lopez-Novoa JM, Bernabeu C (2013) Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. Blood 121:403-415
17. Mundel P, Kriz W (1996) Cell culture of podocytes. Exp Nephrol 4:263-266
18. Kriz W, Gretz N, Lemley KV (1998) Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 54:687-697
19. Sachs N, Sonnenberg A (2013) Cell-matrix adhesion of podocytes in physiology and disease. Nat Rev Nephrol 9:200-210
20. Bergmeier W, Hynes RO (2012) Extracellular matrix proteins in hemostasis and thrombosis. Cold Spring Harb Perspect Biol 4. pii: a005132
21. Lopez-Novoa JM, Bernabeu C (2010) The physiological role of endoglin in the cardiovascular system. Am J Physiol Heart Circ Physiol 299:H959-H974
22. Gougos A, Letarte M (1990) Primary structure of endoglin, an rgd-containing glycoprotein of human endothelial cells. J Biol Chem 265:8361-8364
23. Llorca O, Trujillo A, Blanco FJ, Bernabeu C (2007) Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J Mol Biol 365:694-705
24. Castonguay R, Werner ED, Matthews RG, Presman E, Mulivor AW, Solban N, Sako D, Pearsall RS, Underwood KW, Seehra J, Kumar R, Grinberg AV (2011) Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J Biol Chem 286:30034-30046
25. Alt A, Miguel-Romero L, Donderis J, Aristorena M, Blanco FJ, Round A, Rubio V, Bernabeu C, Marina A (2012) Structural and functional insights into endoglin ligand recognition and binding. PLoS One 7:e29948
26. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J et al (1994) Endoglin, a tgf-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345-351
27. Shovlin CL (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24:203-219
28. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP (1999) Defective angiogenesis in mice lacking endoglin. Science 284:1534-1537
29. Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104:1343-1351
30. Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, Burn J, Diamond AG (2000) Endoglin, an ancillary tgfbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217:42-53
31. Mancini ML, Terzic A, Conley BA, Oxburgh LH, Nicola T, Vary CP (2009) Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis. Dev Dyn 238:2479-2493
32. Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C, Bréant C, Mathivet T, Larrivée B, Thomas JL, Arthur HM, Westermann CJ, Disch F, Mager JJ, Snijder RJ, Eichmann A, Mummery CL (2010) Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 16:420-428
33. Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, Sier CF, ten Dijke P (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70:4141-4150
34. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642-649
35. Valbuena-Diez AC, Blanco FJ, Oujo B, Langa C, Gonzalez-Nuñez M, Llano E, Pendas AM, Díaz M, Castrillo A, Lopez-Novoa JM, Bernabeu C (2012) Oxysterol-induced soluble endoglin release and its involvement in hypertension. Circulation 126:2612-2624
36. Carney EF (2013) Pre-eclampsia: podocyturia predicts pre-eclampsia. Nat Rev Nephrol 9:310
37. Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, Turner ST, Hayman SR, White WM, Brost BC, Rose CH, Grande JP, Garovic VD (2013) Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61:1289-1296
38. Guerrero-Esteo M, Lastres P, Letamendía A, Pérez-Alvarez MJ, Langa C, López LA, Fabra A, García-Pardo A, Vera S, Letarte M, Bernabéu C (1999) Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts. Eur J Cell Biol 78:614-623
39. Tian H, Mythreye K, Golzio C, Katsanis N, Blobe GC (2012) Endoglin mediates fibronectin/alpha5beta1 integrin and tgf-beta pathway crosstalk in endothelial cells. EMBO J 31:3885-3900
40. Smadja DM, Bièche I, Uzan G, Bompais H, Muller L, Boisson-Vidal C, Vidaud M, Aiach M, Gaussem P (2005) Par-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the sdf-1/cxcr4 system. Arterioscler Thromb Vasc Biol 25:2321-2327
41. Smadja DM, Bièche I, Silvestre JS, Germain S, Cornet A, Laurendeau I, Duong-Van-Huyen JP, Emmerich J, Vidaud M, Aiach M, Gaussem P (2008) Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol 28:2137-2143
42. Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken JB, Bischoff J (2006) Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 108:915-921
43. Boscolo E, Stewart CL, Greenberger S, Wu JK, Durham JT, Herman IM, Mulliken JB, Kitajewski J, Bischoff J (2011) Jagged1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31:2181-2192
44. Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, Oettgen P, Bischoff J (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103:194-202
45. Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C (2002) Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem 277:29197-29209
46. Bellon T, Corbí A, Lastres P, Calés C, Cebrián M, Vera S, Cheifetz S, Massague J, Letarte M, Bernabéu C (1993) Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 23:2340-2345
47. Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C (2005) Interaction and functional interplay between endoglin and alk-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 204:574-584
48. Jerkic M, Rivas-Elena JV, Santibanez JF, Prieto M, Rodríguez-Barbero A, Perez-Barriocanal F, Pericacho M, Arévalo M, Vary CP, Letarte M, Bernabeu C, López-Novoa JM (2006) Endoglin regulates cyclooxygenase-2 expression and activity. Circ Res 99:248-256
49. Botella LM, Sánchez-Elsner T, Sanz-Rodriguez F, Kojima S, Shimada J, Guerrero-Esteo M, Cooreman MP, Ratziu V, Langa C, Vary CP, Ramirez JR, Friedman S, Bernabéu C (2002) Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood 100:4001-4010
50. Jerkic M, Rodríguez-Barbero A, Prieto M, Toporsian M, Pericacho M, Rivas-Elena JV, Obreo J, Wang A, Pérez-Barriocanal F, Arévalo M, Bernabéu C, Letarte M, López-Novoa JM (2006) Reduced angiogenic responses in adult endoglin heterozygous mice. Cardiovasc Res 69:845-854
51. Adam PJ, Clesham GJ, Weissberg PL (1998) Expression of endoglin mrna and protein in human vascular smooth muscle cells. Biochem Biophys Res Commun 247:33-37
52. Conley BA, Smith JD, Guerrero-Esteo M, Bernabeu C, Vary CP (2000) Endoglin, a tgfbeta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis 153:323-335
53. Ma X, Labinaz M, Goldstein J, Miller H, Keon WJ, Letarte M, O'Brien E (2000) Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta induced inhibition of smooth muscle cell migration. Arterioscler Thromb Vasc Biol 20:2546-2552
54. Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, Dijke PT, Arthur HM, Mummery CL (2004) Defective paracrine signalling by tgfbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131:6237-6247
55. Luo BH, Carman CV, Springer TA (2007) Structural basis of integrin regulation and signaling. Annu Rev Immunol 25:619-647
56. Eto K, Puzon-McLaughlin W, Sheppard D, Sehara-Fujisawa A, Zhang XP, Takada Y (2000) Rgd-independent binding of integrin alpha9beta1 to the adam-12 and -15 disintegrin domains mediates cell-cell interaction. J Biol Chem 275:34922-34930
57. Pober JS, Sessa WC (2014) Inflammation and the Blood Microvascular System. Cold Spring Harb Perspect Biol 7:a016345
58. Young K, Conley B, Romero D, Tweedie E, O'Neill C, Pinz I, Brogan L, Lindner V, Liaw L, Vary CP (2012) BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. Blood 120:4263-4273
59. Turlo KA, Scapa J, Bagher P, Jones AW, Feil R, Korthuis RJ, Segal SS, Iruela-Arispe ML (2013) β1-integrin is essential for vasoregulation and smooth muscle survival in vivo. Arterioscler Thromb Vasc Biol 33:2325-2335
60. Turner CJ, Badu-Nkansah K, Crowley D, van der Flier A, Hynes RO (2015) α5 and αv integrins cooperate to regulate vascular smooth muscle and neural crest functions in vivo. Development 142:797-808
61. Jovine L, Darie CC, Litscher ES, Wassarman PM (2005) Zona pellucida domain proteins. Annu Rev Biochem 74:83-114
62. Jerkic M, Letarte M (2015) Increased endothelial cell permeability in endoglin-deficient cells. FASEB J 29:3678-3688
63. Mahmoud M, Allinson KR, Zhai Z, Oakenfull R, Ghandi P, Adams RH, Fruttiger M, Arthur HM (2010) Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 106:1425-1433
64. Jerkic M, Rivas-Elena JV, Prieto M, Carrón R, Sanz-Rodríguez F, Pérez-Barriocanal F, Rodríguez-Barbero A, Bernabéu C, López-Novoa JM (2004) Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 18:609-611
65. Jim B, Jean-Louis P, Qipo A, Garry D, Mian S, Matos T, Provenzano C, Acharya A (2012) Podocyturia as a diagnostic marker for preeclampsia amongst high-risk pregnant patients. J. Pregnancy 2012:984630. doi: 10.1155/2012/984630
66. Walshe TE, Saint-Geniez M, Maharaj AS, Sekiyama E, Maldonado AE, D'Amore PA (2009) TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS One 4:e5149